Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS)
Clinical trial NCT04079088 · WITHDRAWN
Trial details
- NCT number
- NCT04079088
- Sponsor
- Biogen
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2024-09-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.